These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11752398)

  • 1. Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter.
    Watabe T; Lin M; Ide H; Donjacour AA; Cunha GR; Witte ON; Reiter RE
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):401-6. PubMed ID: 11752398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells.
    Tran CP; Lin C; Yamashiro J; Reiter RE
    Mol Cancer Res; 2002 Dec; 1(2):113-21. PubMed ID: 12496358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling in R-flurbiprofen-treated prostate cancer: R-Flurbiprofen regulates prostate stem cell antigen through activation of AKT kinase.
    Zemskova M; Wechter W; Bashkirova S; Chen CS; Reiter R; Lilly MB
    Biochem Pharmacol; 2006 Nov; 72(10):1257-67. PubMed ID: 16949054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter.
    Petrigliano FA; Virk MS; Liu N; Sugiyama O; Yu D; Lieberman JR
    Prostate; 2009 Sep; 69(13):1422-34. PubMed ID: 19489029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
    Zhigang Z; Wenlu S
    Prostate; 2007 May; 67(6):653-60. PubMed ID: 17342746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
    Zhigang Z; Wenlv S
    Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative pathways to prostate carcinoma activate prostate stem cell antigen expression.
    Dubey P; Wu H; Reiter RE; Witte ON
    Cancer Res; 2001 Apr; 61(8):3256-61. PubMed ID: 11309275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective expression of murine prostate stem cell antigen in fetal and adult tissues and the transgenic adenocarcinoma of the mouse prostate model of prostate carcinogenesis.
    Ross S; Spencer SD; Lasky LA; Koeppen H
    Am J Pathol; 2001 Mar; 158(3):809-16. PubMed ID: 11238029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity.
    Garcia-Hernandez Mde L; Gray A; Hubby B; Klinger OJ; Kast WM
    Cancer Res; 2008 Feb; 68(3):861-9. PubMed ID: 18245488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of PSCA increases metastasis of TRAMP-induced prostate tumors without altering primary tumor formation.
    Moore ML; Teitell MA; Kim Y; Watabe T; Reiter RE; Witte ON; Dubey P
    Prostate; 2008 Feb; 68(2):139-51. PubMed ID: 18044730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice.
    Yang D; Holt GE; Velders MP; Kwon ED; Kast WM
    Cancer Res; 2001 Aug; 61(15):5857-60. PubMed ID: 11479226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete androgen ablation suppresses prostate stem cell antigen (PSCA) mRNA expression in human prostate carcinoma.
    Zhigang Z; Wenlu S
    Prostate; 2005 Dec; 65(4):299-305. PubMed ID: 16015594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts.
    Saffran DC; Raitano AB; Hubert RS; Witte ON; Reiter RE; Jakobovits A
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2658-63. PubMed ID: 11226295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model.
    Hsieh CL; Xie Z; Yu J; Martin WD; Datta MW; Wu GJ; Chung LW
    Prostate; 2007 May; 67(7):685-91. PubMed ID: 17342752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression.
    Rubinchik S; Wang D; Yu H; Fan F; Luo M; Norris JS; Dong JY
    Mol Ther; 2001 Nov; 4(5):416-26. PubMed ID: 11708878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells.
    Morgenroth A; Cartellieri M; Schmitz M; Günes S; Weigle B; Bachmann M; Abken H; Rieber EP; Temme A
    Prostate; 2007 Jul; 67(10):1121-31. PubMed ID: 17492652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
    Latham JP; Searle PF; Mautner V; James ND
    Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
    J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
    Kim S; Lee JB; Lee GK; Chang J
    Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.